incb039110 and Primary-Myelofibrosis

incb039110 has been researched along with Primary-Myelofibrosis* in 1 studies

Trials

1 trial(s) available for incb039110 and Primary-Myelofibrosis

ArticleYear
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.
    Haematologica, 2017, Volume: 102, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Azetidines; Cytokines; Female; Gene Frequency; Humans; Isonicotinic Acids; Janus Kinase 1; Male; Middle Aged; Mutation; Primary Myelofibrosis; Protein Kinase Inhibitors; Severity of Illness Index; Treatment Outcome

2017